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ABSTRACT
6-Phenylpyrrolocytidine (PhpC), a structurally con-
servative and highly fluorescent cytidine analog,
was incorporated into oligoribonucleotides. The
PhpC-containing RNA formed native-like duplex
structures with complementary DNA or RNA. The
PhpC-modification was found to act as a sensitive
reporter group being non-disruptive to structure and
the enzymatic activity of RNase H. A RNA/DNA
hybrid possessing a single PhpC insert was an
excellent substrate for HIV-1 RT Ribonuclease H
and rapidly reported cleavage of the RNA strand
with a 14-fold increase in fluorescence intensity.
The PhpC-based assay for RNase H was superior
to the traditional molecular beacon approach in
terms of responsiveness, rapidity and ease (single
label versus dual). Furthermore, the PhpC-based
assay is amenable to high-throughput microplate
assay format and may form the basis for a new
screen for inhibitors of HIV-RT RNase H.
INTRODUCTION
The continuing emergence of drug resistant variants of the
human immunodeﬁciency virus (HIV) calls for new tools
to combat this epidemic (1). Current clinical treatment of
HIV targets essential enzymatic activities associated with
the reverse transcription of the viral genome and the
protease activity required for maturation of protein
components of the virus. The most eﬀective control of
the disease has been achieved with combination therapy
targeting these pathways simultaneously. The inclusion of
additional targets in a combination drug regimen is highly
desirable for potent and long-term disease management.
The ribonuclease H (RNase H) activity associated with
HIV-reverse transcriptase (HIV-RT) degrades the viral
RNA genome in RNA/DNA hybrids (2), and has been
identiﬁed as a potential target for antiretroviral therapy
as it is required for virus infectivity (3); yet there are no
antiRNase H agents in clinical use. Few inhibitors of HIV-
1 RNase H were identiﬁed until the transition of testing
methods from gel-based techniques to ﬂuorescent assays
amenable to high-throughput screening (HTS) (4–8). The
most widely used assay was developed by Parniak and co-
workers (6) and utilizes a two label, molecular beacon
strategy (9) in which the RNA strand is labeled with a
30-terminal ﬂuorophore (ﬂuorescein, F) and a DNA
strand with a quencher (dabcyl, Q) at the 50-terminus
(Scheme 1).
Fluorescent studies involving nucleic acids most often
utilize luminescent tags such as ﬂuorescein or rhodamine
sometimes in combination with a quencher such as
4-(dimethylaminoazo)benzene (dabcyl). However, these
probes can be perturbing to the processes under investiga-
tion due to the steric bulk or non-polar groups they intro-
duce to DNA and RNA. Through our own studies on
inhibitors of HIV-1 RNase H, we have observed that the
50-dabcyl quencher substantially reduces the catalytic eﬃ-
ciency of RNase H for its RNA/DNA substrate (SI).
The use of intrinsically ﬂuorescent nucleotide base
analogs oﬀers a more conservative approach to ﬂuores-
cence labeling of nucleic acids. Using phosphoramidite
solid-phase synthesis (10), a ﬂuorescent nucleotide can
be incorporated at any position on an oligomer without
the use of linkers or postsynthetic modiﬁcations. In
addition, the ﬂuorescence intensity of many base
modiﬁed nucleotides are responsive to changes in their
microenvironment, making them reporters for nucleic
acid structure and dynamics (11). Despite these advan-
tages, few ﬂuorescent nucleobase analogs have found
widespread use as a tool for molecular biology,
2-aminopurine (12) and the pteridine (13) base analogs
being historically the most important. Recent work from
Tor and others have elegantly demonstrated the value and
utility in the design and discovery of new ﬂuorescent
nucleobases (14–17). Despite these and other recent
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cent cytidine analogs that demonstrate responsiveness to
their microenvironment and state of hybridization (18)
thus motivating this work.
The success of a ﬂuorescent nucleobase analog as a
useful reporter resides in its ability to form proper
Watson–Crick base pairs, thermostability in double
stranded nucleic acids, changes in ﬂuorescence with diﬀer-
ent hybridization states, recognition of nucleic acid
processing/binding enzymes, and its ﬂuorescence intensity.
The cytidine analogs pyrrolocytidine (pC, Figure 1) with
6-methyl substitution (MepC) (19–21) satisﬁes the above
criteria as a ﬂuorescent reporter, though its ﬂuorescence
intensity, as manifested by a modest quantum yield (),
lags behind competing chemistries ultimately making
it a less sensitive probe. One of our laboratories has
shown that the low quantum yield of MepC can be
remedied by substituting the C-6 position with an
aromatic group without any penalties on sensitivity or
base pairing ﬁdelity (22–24).
We have now synthesized the ribonucleoside of
6-phenylpyrrolocytidine (PhpC, Figure 1) and found
that, like its DNA and PNA homologs, it ranks among
the brightest C-analog luminiophores. The ﬂuorescence of
PhpC is sensitive to its microenvironment, and displays
a  max excitation (360nm) and  max emission (466nm)
signiﬁcantly red-shifted from the absorption of other
biomolecules. The combination of these properties
makes PhpC unique among ﬂuorescent nucleobase
analogs and has enabled its use as a ﬂuorescent reporter
group in an RNase H assay. Maintaining the same RNA
sequence as the traditional FQ-based assay (6) (RNA-1,
Table 1), we replaced a single rC nucleoside with PhpC
close to the 30-terminus of the RNA/DNA hybrid,
PhpC-1, where it exhibits low ﬂuorescence (quenched
state) as depicted in Scheme 2. Treatment with HIV-1
RT RNase H generates an RNA tetranucleotide (25)
bearing PhpC, and quickly dissociates from its DNA
complement with a concomitant dramatic increase in
ﬂuorescence emission.
MATERIALS AND METHODS
50-O-(4,40-dimethoxytrityl)-5-iodouridine (2)
Uridine (2.44g, 10mmol) was added to a mixture of
iodine (2.54g, 10mmol) and silver sulfate (3.12mg,
10mmol) in methanol (200ml) at room temperature
(r.t.). The mixture was stirred for 8min, after which time
the yellow solid was removed by ﬁltration and the ﬁltrate
was evaporated under reduced pressure. The residue was
co-evaporated with 2:1 MeOH/H2O (50ml) to remove
iodine (which sublimed away) and crystallized from
water to give pure 5-iodouridine as a white solid (4.44g,
60%). 5-Iodouridine (2.22g, 6mmol) was dissolved in
pyridine (30ml) and 4,40-dimethoxytritylchloride (2.64g,
7.8mmol) was added in four portions during a 4h
period. After an additional 2h of stirring at r.t. the
reaction was quenched by adding 1ml of 5% NaHCO3
for 15min. The solution was concentrated under reduced
pressure, redissolved in 50ml of dichloromethane (DCM)
and washed with a solution of 5% NaHCO3 (30ml). The
product was further extracted with two 25ml portions of
DCM, and the combined organic layer was dried over
Scheme 2. Reporting via a single ﬂuorescent nucleotide analogs.
*C=6-phenylpyrrolocytidine (PhpC).
Scheme 1. Representation of ﬂuorescent RNase H assay using a dual
label system employing a ﬂuorophore and a quencher.
Figure 1. The structure of cytidine (C) and unsubstituted pC, with
numbering, compared to PhpC. R=ribose or 20-deoxyribose.
Table 1. Oligonucleotides used in RNase H assays and Tm data
Name Sequence (50–30)
a Tm ( C)
b
DNA-1 RNA-2
RNA-1 GAU CUG AGC CUG GGA GCU 65.1 78.5
PhpC-1 GAU CUG AGC CUG GGA G*CU 64.7 78.8
PhpC-2 GAU CUG AGC *CUG GGA GCU 67.5 80.8
aPhpC indicated by *C.
bTm values represent the average of at least 3 independent experiments
within 1 C.
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residue was then puriﬁed by silica gel column chromatog-
raphy using an elution gradient with DCM/MeOH/TEA
(98:1:1 to 96:3:1). Fractions containing 2 were
evaporated to give a white foam (3.72g, 55%).
1H NMR
(400MHz, CDCl3): d=8.14 (s, 1H), 7.21–7.42 (m, 11H),
6.84 (m, 4H), 6.31 (dd,
1J=6.8Hz,
2J=5.9Hz, 1H),
4.55 (m, 1H), 4.07 (m, 1H), 3.79 (s, 6H), 3.78 (m, 1H),
3.36–3.44 (m, 2H), 2.46–2.64 (m, 1H), 2.30–2.33 (m, 1H)
p.p.m. ESI-TOF (m/z) 695.4 (M+Na).
50-O-(4,40-dimethoxytrityl)-5-(phenylethynyl)uridine (3)
In a 50ml Schlenk ﬂask, 50-O-(4,40-dimethoxytrityl)-5-
iodouridine (0.67g, 1mmol) was mixed with dry THF
(15ml), phenylacetylene (6mmol), Et3N (4mmol) and
was then deoxygenated with N2 for 5min. Subsequently,
Pd(PPh3)4 (0.1mmol) and CuI (0.2mmol) was added and
the mixture was stirred in the dark for 36h at r.t. The
solution was then ﬁltered, concentrated to dryness,
redissolved in CH2Cl2 (50ml) and washed sequentially
with 5% NaHCO3 (30ml), 5% EDTA (30ml) and 5%
NaHCO3 (30ml) and dried over Na2SO4. The solvent
was evaporated and the resulting residue was puriﬁed by
silica gel column chromatography using a gradient of
hexanes/acetone/TEA (78:20:2 to 40:58:2) to provide
product 3 as a pure compound in 60% yield (0.39g).
1H
NMR (400MHz, CDCl3) d=8.15 (s, 1H, 6-H); 7.05–7.42
(m, 14H, ArH), 6.74–6.78 (m, 4H, ArH), 5.80
(d,
3J=4.0Hz, 1H, H-10), 4.44, 4.34, 4.30 (3m, 3H each,
H-20, H-30, H-40), 3.66 and 3.65 (s, 6H, 2 OMe), 3.44(d,
1H,
2J=12.0Hz,
3J=4.0Hz, CHAHB-50), 3.29 (d, 1H,
2J=12.0Hz, CHAHB-50).
13C NMR(100MHz, CDCl3)
d=164.89, 158.71, 152.42, 144.68, 142.24, 135.92,
135.74, 131.84, 130.24, 130.12, 128.21, 128.09, 127.12,
122,99, 113.52, 100.68, 93.56, 90.62, 87.09, 84.99, 81.27,
76.12, 71.28, 71.28, 63.36, 55.33. HRMS (EI) m/z
calcd[Na]: 669.2913; found: 669.2924.
50-O-(4,40-dimethoxytrityl)-6-phenylfuranouridine (4)
Compound 3 (0.645g, 1mmol) was dissolved in
deoxygenated acetone (10ml), then AgNO3 (0.1mmol)
was added. The reaction mixture was stirred at r.t. in
the dark for 24h and monitored by TLC (5–15%
MeOH/DCM) until reaction completion. After ﬁltration
and concentration of the solution in vacuum, the solid
residue was puriﬁed by silica gel column chromatography
using an elution gradient of hexanes/EtOAc/TEA
(50:50:2 to 15:85:2) to provide 4 (0.450g, 70%).
1H
NMR (400MHz, CDCl3) d 8.90 (s, 1H, 4-H); 7.24–7.64
(m, 14H, ArH), 6.81–6.84 (m, 4H, ArH), 6.50 (d, 1H,
3J=2.0Hz, H-10), 5.77 (s, 1H, 5-H), 5.56 (m, 1H, H-20),
4.48 (m, 1H, H-30), 34.39 (m, H, H-40), 3.72, 3.74 (2s, 6H,
2OMe), 3.55 (m, 2H, H-500).
13C NMR (100MHz,
CDCl3): d 171.38 (C-7a); 158.60(C-2), 158.55(C-6),
155.04 (Carom), 143.91 (Carom), 137.35 (C-4) 135.61,
135.18 (2 Carom), 130.16, 129.99 (2 CHarom), 129.35
(Carom), 128.70, 128.34, 128.20, 128.08 (4 CHarom),
126.98 (Carom), 124.57, 113.32 (2 CHarom), 108.40 (C-5),
98.10 (C-4a), 93.23 (C-10), 87.00 (C–Ph(Ph–OCH3)2) 83.77
(C-40), 75.67 (C-20), 68.72 (C-30), 61.14 ( CH2O), 60,29
(C-50), 55.45 (2CH3OAr). ESI-TOF (m/z) 669.2 (M+Na).
50-O-(4,40-dimethoxytrityl)-6-PhpC (5)
A pressure bottle with compound 4 (0.64g, 1.0mmol),
concentrated NH3OH (4ml) and MeOH (6ml) was
stirred at 55 C for 24h. Progress of the reaction was
followed by TLC (Rf 0.38 in 10:1 DCM/MeOH). After
completion of the reaction (24h), the yellow solid was
ﬁltered and then dissolved in CH2Cl2 and dried over
Na2SO4 and the solvent was removed and the residue
was further dried under vacuum overnight (0.57g, 60%).
1H NMR (400MHz, CDCl3) d=11.57 (s, 1H), 8.83
(s, 1H), 7.57 (d, 2H), 7.37 (d, J=7.5, 3H), 7.33–7.06
(m, 13H), 7.03 (t, J=7.55, 1H), 6.75 (dd, J=8.8, 6.9,
4H), 6.13 (s, 1H), 5.52 (s, 1H), 4.48 (s, 1H), 4.46 (d,
J=5.8, 1H), 4.32 (d, J=5.8, 1H), 3.69, 3.58 (m, 2H),
3.63 (d, J=10.2, 6H).
13C NMR (101MHz, CDCl3)
d=171.40, 159.27, 158.88, 158.82, 155.38, 144.40,
140.89, 136.54, 136.20, 135.71, 130.48, 130.30, 130.26,
128.90, 128.62, 128.38, 127.25, 125.50, 113.65, 113.43,
111.17, 97.22, 93.44, 87.22, 83.90, 76.23, 69.36, 61.73,
60.64, 55.37, 55.34. HRMS (EI) m/z calcd for
C38H36N3O7: 645.2475; found [M+H]: 646.2585.
50-O-(4,40-Dimethoxytrityl)-20-O-tert-butyldimethylsilyl-6-
PhpC (6)
To a 25ml round-bottom ﬂask containing 315mg
(0.48mmol) of compound 5 dissolved in 2ml of dry
DMF, TBDMS-Cl (88mg, 0.58mmol) and imidazole
(82mg, 1.2mmol) was added and stirred overnight. The
formation of the 20-O-silyl and 30-O-silyl products were
monitored by TLC (Rf values of 0.56 and 0.13, respec-
tively in 1:3 EtOAc/DCM) until the starting material
was consumed. The reaction was worked-up in 5%
NaHCO3, ﬁltered over MgSO4 and evaporated to
dryness. The 20-O-silyl regioisomer was obtained by
silica gel column chromatography using a gradient of
hexanes-ethyl acetate from 1:3 to 1:1 keeping 1% TEA
in the solvents. The remaining crude 20- and 30-regioisomer
were mixed for 2h in 5ml of pyridine and three drops of
water to form an equal mix of isomers. From this mix, the
20-regioisomer was again puriﬁed by silica gel and both
puriﬁed fractions were evaporated over high vacuum to
give 213mg of a yellow powder (58% yield).
1H NMR
(500MHz, DMSO) d=11.76 (s, 1H), 8.75 (s, 1H), 7.61
(d, J=7.6, 2H), 7.47–7.10 (m, 16H), 6.92 (d, J=4.1, 4H),
5.78 (s, 1H), 5.41 (s, 1H), 5.20 (d, J=6.1, 1H), 4.37 (s,
1H), 4.15 (s, 1H), 4.11 (d, J=8.3, 1H), 3.70 (d, J=6.6,
7H), 3.45 (dd, J=9.9, 58.4, 2H), 0.89 (s, 9H), 0.15 (s, 3H),
0.10 (s, 3H) p.p.m.
13C NMR (126MHz, DMSO)
d=160.38, 158.89, 158.84, 154.53, 144.68, 139.67,
136.79, 136.67, 136.35, 135.72, 130.82, 130.70, 130.54,
130.31, 129.70, 129.53, 128.74, 128.58, 127.53, 125.43,
125.31, 114.10, 114.01, 109.63, 97.04, 92.40, 92.28, 86.88,
82.06, 81.95, 77.58, 77.46, 68.37, 61.76, 55.76, 55.62, 26.45,
26.41, 18.66,  4.12,  4.20p.p.m. ESI-TOF (m/z) 782.4
(M+Na).
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O-(2-cyanoethyldiisopropyl-phosphoramidite)-6-PhpC (7)
Compound 6 (213mg, 0.28mmol) was sublimed in 3ml of
distilled benzene over dry ice on high vaccum overnight,
purged with argon, and dissolved in freshly distilled
THF. Dry diisopropylethylamine (0.2ml, 1.12mmol)
and diisopropylamino-(2-cyanoethyl)-phosphoramidic
chloride (63ml, 0.28mmol) were added and the reac-
tion was stirred for 2h and monitored by TLC
(5% methanol in DCM). At the end of this time, the
reaction was washed with 5% NaHCO3, dried over
sodium sulfate and loaded on a silica gel column
neutralized in 2.5% triethylamine in hexane. The
puriﬁed phosphoramidite diastereomers were eluted in
6:4 haxane-ethyl acetate, rotary evaporated and
sublimed in 3ml of distilled benzene overnight to yield a
yellow foam (240mg, 0.25mmol).
31P NMR (200MHz,
ACN) d=151.3 (s, 1P), 149.5 (s, 1P) p.p.m. ESI-TOF
(m/z) 982 (M+Na).
Oligonucleotide synthesis
Solid-phase synthesis of oligonucleotides was carried out
on an Applied Biosystems 3400 DNA synthesizer using
standard protocols (26). Coupling yields for PhpC were
comparable to standard 20-O-TBDMS ribonucleonucleo-
side phosphoramidites based on analytical denaturing
PAGE (SI). Cleavage from the solid support was carried
out in a 3:1 mixture of NH4OH:EtOH at r.t for 48h, and
removal of the 20-O-silyl protecting groups was achieved
by treatment with distilled triethylammonium
trihydroﬂuoride for 48h. The crude, deprotected
oligonucleotides were precipitated in ice-cold butanol
and 3M sodium acetate and quantitated by their UV
absorbance at 260nm on a Cary-300 UV-VIS
spectrophotometer (Varian Inc.). Crude products
were then analyzed and puriﬁed by denaturing PAGE
(7M urea) and visualized by UV shadowing using
254nm light for non-ﬂuorescent oligonucleotides, and
365nm light for ﬂuorescent oligonucleotides. Full-length
products were excised from the gels using a sterile surgical
blade, and eluted in sterile water. The eluted products
were desalted by size-exclusion chromatography on G-25
Sephadex (GE Healthcare) and quantitated.
Thermal denaturation and circular dichroism studies
For UV–Vis thermal denaturation experiments oligo-
nucleotides were analyzed in 1ml solutions at 1mM
concentrations in a buﬀer of 10mM sodium phosphate
at pH 7.0 and 50mM NaCl. Double-stranded oligonucleo-
tides were annealed in equimolar amounts by heating to
95 C and then slowly cooling to r.t. on a heating block.
Thermal denaturation experiments were performed on
a Cary-300 UV–Vis spectrophotometer (Varian Inc.)
equipped with a 6   6 cell changer and Peltier temperature
controller. Samples were heated from 10 Ct o9 5  Ca ta
rate of 0.5 C/min and the change in absorbance was
measured every 1.0 C. The melting temperature (Tm)
values were obtained by the baseline (alpha) method,
and deﬁned as the point when the mole fraction of
duplex was equal to 0.5. These values represent the
averages of at least three independent experiments.
Fluorescent thermal denaturation plots were obtained in
a similar fashion on a Cary Eclipse ﬂuorescent spectro-
photometer equipped with a multicell Peltier temperature
controller and automated polarization accessories.
Measurements were carried out in 1cm 1 cm quartz
cells in 2ml volumes and 1mM concentration of
oligonucleotides
Circular dichroism (CD) spectra were obtained using a
Jasco J-800 spectropolarimeter. Samples were prepared in
the same fashion as with Tm experiments. Scans were per-
formed in triplicate at 20 C at a rate of 50nm/min from
350 to 190nm. The data were averaged, corrected against
a blank and smoothed using the Spectra Manager CD
software provided by the manufacturer.
RNase H assays
Wild-type p66/p51 HIV-1 RT was a generous gift from
Dr M. Go ¨ tte (McGill), prepared by his group as described
earlier (2). RNA substrates were 50-radiolabeled with g-
32P
ATP by T4 polynucleotide kinase (Fermentas) using the
manufacturer’s recommended procedure. The DNA and
50-
32P labeled RNA strands were combined in a 1.2:1
ratio and annealed by heating to 95 C followed by slow
cooling to r.t. HIV-1 RT (2.5nM ﬁnal concentration) was
incubated for 10min at 37 C in RNase H reaction buﬀer
(50mM Tris–HCl, pH 7.8, 60mM KCl, 5mM MgCl2,
0.1mM DTT and 0.01% Tween-20). The reactions were
initiated by the addition of duplexed RNA/DNA
substrate to a concentration of 50nM. Aliquots were
removed at various times as indicated in Figure 2 and
stopped by the addition of an equal volume of loading
buﬀer (98% deionized formamide, 1mg/ml bromophenol
blue and 1mg/ml xylene cyanol) followed by heat inacti-
vation at 95 C for 5min. Cleavage products were resolved
on a 16% denaturing polyacrylamide gel and visualized by
autoradiography.
Fluorescent RNase H assays of HIV-1 RT RNase
H activity was monitored by the changes in emission
of PhpC on a Cary Eclipse ﬂuorescent spectrophotometer
equipped with a multicell Peltier temperature controller
and automated polarization accessories. These assays
were run in 2ml volumes in identical buﬀer conditions
as the gel-based assays, but were initiated by the
addition of MgCl2 (5mM ﬁnal concentration) in
order to monitor ﬂuorescence prior to cleavage by HIV-
1 RT. Substrate concentrations varied from 1 to 0.2mM
and enzyme concentrations were changed to 25 or 5nM,
respectively. The ﬂuorescence intensity was monitored
every 15s. PhpC RNase H assays were monitored
at an excitation wavelength of 360nm (5nm
bandwidth) and emission wavelength of 465nm (5nm
bandwidth). The ﬂuorescein-RNA/dabcyl-DNA pair was
monitored at an excitation wavelength of 485nm
(5nm bandwidth) and emission wavelength of 520nm
(5nm bandwidth). Fluorescence polarization (FP)
RNase H assays were run under identical conditions as
stated above.
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RNase H activity of HIV-1 RT was monitored on a
Gemini XS and M5 spectroﬂuorometers by Molecular
Devices in 96-half well opaque plates. FP measurements
in 96-well microplates were performed on a BioTek
Synergy 4. Experiments were run under identical buﬀer
conditions as gel-based assays in a ﬁnal volume of
100ml. Reactions were initiated by the addition of a
50ml solution containing HIV-1 RT and MgCl2. The con-
centration of substrate was varied from 1mM to 10nM,
and enzyme concentrations varied from 25 to 5nM,
respectively. Excitation and emission wavelengths for
PhpC were 360 and 465nm, respectively, and 485 and
520nm for the dabcyl/ﬂuorescein assay. To determine
Km, Vmax and kcat, the initial velocity of RNase H
cleavage was measured under a ﬁxed concentration
HIV-1 RT (1nM) and the substrate concentration was
varied from 10 to 900nM. The IC50 of DHBNH, a
sample of which was generously provided by Dr M.A.
Parniak, was determined on two separate days and was
run in triplicate using 200nM substrate and 1.5nM HIV-1
RT in 1% DMSO. Eight concentrations of DHBNH were
dispensed by two-fold serial dilutions starting from 50mM
of the inhibitor.
RESULTS AND DISCUSSION
Physical properties of RNA containing PhpC
PhpC-containing oligoribonucleotides were obtained by
conventional phosphoramidite chemistry in a similar
manner as deoxy-PhpC (22–24) with the 20-OH group
protected as the tert-butyldimethylsilyl ether (27,28)
(Scheme 3). Thermal denaturation studies of these
sequences hybridized to complementary DNA (DNA-1)
and RNA (RNA-2) were carried out (Table 1). PhpC-1
showed comparable binding aﬃnity to unmodiﬁed
controls, whereas the PhpC at a central position, PhpC-
2, displayed a 2 C increase in thermal stability that is
ascribed to greater p-stacking, which is consistent with
the increased hypochromicity observed in the thermal
denaturation proﬁles (SI), and previous reports of PhpC
in PNA and DNA (22,24). The PhpC insert was also
shown to be exceptionally well-tolerated in RNA/RNA
duplexes by CD spectroscopy (SI), as the CD spectra
overlapped nearly identically with the native strands in
shape and intensity. It is noteworthy that despite the
changes in global conformation that accompany the tran-
sition for B-form (dsDNA) through hybrid duplexes
(RNA:DNA) to A-form (dsRNA) that the modiﬁed
C5-face of cytosine is well accommodated based on Tm
and CD measurements. Although there is a scarcity of
data reporting on conformation for C5-modiﬁed
pyrimidines in dsRNA or hybrid RNA:DNA duplexes,
Tm data indicate that modest modiﬁcations such as
halogens (29) and alkyl/alkynyl (30) may be modestly
stabilizing, as we have observed for PhpC.
Fluorescence properties of RNA containing PhpC
The ﬂuorescence parameters of PhpC as a free nucleoside,
and when incorporated in short oligomers, single-stranded
18-mers and duplexed to DNA or RNA are given in
Table 2. The PhpC nucleoside (1) and PhpC nucleoside
monophosphate (2) displayed similar ﬂuorescence inten-
sity and quantum yields of 0.31 and 0.29, respectively, a
12-fold increase from a reported 6-methylpyrrolocytidine
(31) value (0.023). Thus, it appears that the phosphate
group does not play a role on the ﬂuorescence intensity.
Comparing the trinucleotides, G-PhpC-U (3), C-PhpC-U
(4), U-PhpC-U (5) and (6) A-PhpC-U the ﬂuorescence
intensity and quantum yield is dependent on the nature
of neighboring bases, with 3 (neighboring guanine)
showing a reduced quantum yield () as was reported
Scheme 3. Synthesis of 6-Phenylpyrrolocytidine phosphoramidite (7). a. I2, AgSO4, MeOH. b. DMT-Cl, py. c. phenylacetylene, DMF, Pd(PPh3)4,
CuI, NEt3. d. AgNO3, acetone. e. NH4OH, MeOH, 55 C. f. TBDMS-Cl, imidazole, DMF. g. (iPr)2NP(Cl)O(CH2)2CN, THF, NiPr2Et.
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suggested that base-stacking interactions can cause dimi-
nution of  by aﬀecting the strength of the oscillator for
the ﬂuorescence transition (31), which is consistent with
our observations, although quenching of the ﬂuorescence
by intrastrand electron transfer cannot be discounted. The
U–PhpC–U trinucleotide had the highest observed
quantum yield of the series (=0.41), which is likely
due to shielding of the ﬂuorophore from solvent
(dynamical quenching) while not introducing other
compensating non radiative deactivation pathways.
Interestingly, the 18-mer single stranded PhpC-1 had the
same ﬂuorescence intensity and quantum yield as the
trinucleotide 3, where PhpC had the same nearest
neighbors. This trend did not continue with PhpC-2
(=0.13) and its analogous trinucleotide 4 (=0.24).
In this case, it appears that PhpC is quenched in the longer
single-stranded RNA sequence by 50%, which may be due
to better stacking interactions in a central position;
however, length and base composition may play a
greater role for shorter PhpC containing oligonucleotides
that are conformationally more ﬂexible.
Oligonucleotides containing pC analogs have
consistently shown ﬂuorescence quenching upon duplex
formation (22–24,33–35). The ﬂuorescence of PhpC-1
hybridized to DNA (8) and RNA (9) also showed  75%
quenching. An increase in ﬂuorescence as the duplexes
denature could be monitored by thermal denaturation
proﬁles, and the mid-point of the transition corresponds
to the Tm determined by UV absorbance (SI). The ﬂuo-
rescence emission when PhpC-2 bound to DNA (11) and
RNA (12) complementary strands surprisingly increased.
This is unexpected based on our previous work with
modiﬁed oligonucleotides, and to our knowledge is the
ﬁrst example of a pC analog showing increased ﬂuores-
cence emission with hybridization. These observations are
consistent with Thompson’s recent study that proposed
that the changes in quantum yield of pC are not only
dominated by base stacking, which is responsible for
much of the changes in ﬂuorescence for 2-AP (31), but
possibly by collisional deactivation from solvent. We
observed a transition in the ﬂuorescent thermal
denaturation curve of single-stranded PhpC-1 (SI) and
PhpC-2 (not shown) indicating that some quenching in
single strands is contributed by base stacking. The
dramatic quenching of ﬂuorescence normally observed
during duplex formation and speciﬁc hydrogen bonding
to guanine may be due to base pairing mediated electron
transfer, which leads to non-radiative relaxation of the
electronically excited state. Currently, this explanation
awaits experimental support. It is clear from these
results and the limited studies on MepC, that there are a
variety of factors that aﬀect the ﬂuorescence of PhpC
including the sequence context (neighboring bases) and
hybridization state along with microsequence eﬀects.
RNase H assays
The PhpC-containing RNA were determined to be excel-
lent substrates for HIV-1 RT RNase H by standard
50-
32P-label/PAGE assay (Figure 2), unlike the FQ
system, which compromises enzymatic activity (SI).
Furthermore, no aberrant cleavage products were
generated as was previously observed with deoxy-MepC
inserts on the polypurine tract of HIV-1 RT (36).
Subsequently, the RNase H activity was monitored
ﬂuorimetrically. Duplex 8 proved to be remarkably
responsive and gave the largest ﬂuorescence change
(14-fold) between the hybrid duplex and the cleavage
product (Figure 3). This was easily followed in kinetic or
end-point mode. The increase in ﬂuorescence was so
dramatic that it is visible to the naked eye (Figure 3,
inset). We compared the RNase H cleavage of PhpC-1,
to the classic RNA-30-ﬂuorescein/DNA-50-dabcyl (FQ)
assay (6) (Figure 4) by running them simultaneously at
1mM substrate concentrations. We found that the FQ
assay has higher ﬂuorescence signal due to the greater
brightness of ﬂuorescein, but the PhpC-1 assay generated
cleavage products with greater relative ﬂuorescence
compared with the intact substrates (14- versus 8-fold).
As observed in gel-based assays, the PhpC insert did not
slow cleavage as did the FQ substrate resulting in a sub-
stantial gain in analysis time. The end point of cleavage Table 2. Fluorescent properties of PhpC and oligonucleotides con-
taining single PhpC inserts
Entry Name Fluorescence
intensity
a
Quantum
yield
b 
FP
c
1 PhpC 51 0.31 <0.02
25 0-PO4-PhpC 47 0.29 <0.02
3 G-PhpC-U 36 0.11 0.03
4 C-PhpC-U 104 0.24 0.03
5 U-PhpC-U 134 0.41 0.03
6 A-PhpC-U 106 n.d. 0.03
7 PhpC-1 35 0.11 0.21
8 PhpC-1:DNA-1 7.8 0.035 0.28
9 PhpC-1:RNA-2 9.5 n.d. 0.30
10 PhpC-2 38 0.13 0.22
11 PhpC-2:DNA-1 80 0.20 0.27
12 PhpC-2:RNA-2 69 n.d. 0.28
aOne micro molar samples measured in 10mM phosphate buﬀer (pH
7.0) and 50mM NaCl at 25 C,  ex=360nm;  emm=465nm
bSee Supporting Information for Quantum Yield determination.
cFP measured in identical conditions as footnote a.
n.d. signiﬁes not determined.
Figure 2. 50-
32P-labeled PAGE assay for HIV-1 RT RNAase H
activity. Arrowheads indicate substrate (s) and major cleavage
product (c).
Nucleic Acids Research,2010, Vol.38, No. 3 1053(90% completion) was achieved in  20min for 8 versus
130min for FQ.
While a labeled DNA strand was found to be
ﬂuorimetrically responsive to the cleavage of its unlabeled
RNA complement (data not shown), an advantage of
incorporation of the ﬂuorescent nucleoside into the
RNA strand is that it gets processed by RNase H into
fragments that are much smaller than the hybrid duplex.
The substantial change in mass/size of the ﬂuorescent
moiety may be detected by changes in FP (33). As seen
in Table 1, FP values increase with increasing molecular
weight as expected for molecules undergoing less
Brownian motion. RNase H mediated cleavage of
PhpC-1:DNA was readily monitored in real-time by FP
(Figure 5) in a similar fashion to the RNase H assay
developed by Pﬁzer (7).
For application of this assay to screen for inhibitors of
RNase H activity, it is advantageous to monitor polariza-
tion as well as ﬂuorescence intensity. FP can discern
molecules that quench the ﬂuorophore producing false
hits (7). With the versatility of PhpC we have demon-
strated that both ﬂuorescence intensity (which reports on
hybridization/base stacking) and FP (which reports on the
size of the molecule containing the ﬂuorophore) can be
monitored simultaneously using only one probe.
RNase H assays on 96-well plates
Although ﬂuorescent spectrophotometers are far more
sensitive, it is desirable to adapt assays to ﬂuorescent
microplate readers that are amenable to HTS. Since
duplex 8 was the most ﬂuorescent and responsive sub-
strate for RNase H activity, it was tested in 96-well plate
spectroﬂuorometers by ﬂuorescence intensity (Figure 6)
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Figure 4. Comparison the change in ﬂuorescence emission intensity for
the PhpC-1 RNase H assay (red curve) compared to the classic
Fluorescein/Dabcyl assay (black curve). Both substrates were treated
with HIV-1 RT RNase H activity simultaneously in identical conditions
at a concentration of 1mM scanning at the  max excitation and emission
for both ﬂuorescein (485/520nm) and PhpC (360/465nm).
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Figure 6. Fluorescence HIV-1 RT RNase H assay of 1mM PhpC-
1:DNA-1 monitored by a 96-well plate spectroﬂuorimeter. Colored
triangles represent reactions in three individual wells, with the red
curve representing their average. The average of three controls
without enzyme is represented by the black curve.
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Figure 3. Fluorescence emission spectra of PhpC nucleotide (1, black),
PhpC-1 single stranded (2, red), PhpC-1:DNA-1 duplex (3, blue) and
PhpC-1:DNA-1 after RNase H cleavage by HIV-1 RT (4, green).
Visual changes in ﬂuorescence of the same solutions under UV365
light, at 1mM concentration (inset).
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Figure 5. Monitoring the RNase H activity of HIV-1 RT on PhpC-
1:DNA-1 by ﬂuorescence polarization (black curve). The inset shows
the ﬂuorescence intensity with the excitation and emission ﬁlters
parallel (blue curve) and perpendicular (green curve).
1054 Nucleic Acids Research, 2010,Vol.38, No. 3and FP (SI). Using identical reaction conditions used in
the cuvettes (1mM substrate and 25nM HIV-1 RT),
Figure 6 shows very good signal to noise and response
to RNase H cleaveage (10-fold increase). We later tested
the limits of sensitivity of the assay and found we could
still monitor RNase H activity down to 10 nM substrate
concentration (60nM in FP mode), which is comparable
to
32P PAGE assays
We determined the kinetic parameters Km (54±
3.3nM), Vmax (0.31nmols/min) and a kcat of 6/min of
duplex 8 for HIV-1 RT RNase H (SI). Since this assay
will ultimately be used to screen potential inhibitors of
RNase H, a known inhibitor of HIV-1 RT RNase H,
namely DHBNH, was tested in this assay. Our single-
label assay demonstrated that DHBNH was able to
inhibit RNase H activity in a dose-dependent manner
with an IC50 of 5mM, which is consistent with previous
results (37).
CONCLUSIONS
This work demonstrates the signiﬁcant advantages of
base-modiﬁed nucleosides, such as PhpC, compared with
traditional ﬂuorophores: one single PhpC insert can act as
a sensitive reporter group that is non-disruptive to the
structure and enzymatic activity. Although ﬂuorescein is
a substantially brighter luminophore, the PhpC-based
assay for RNase H oﬀers several advantages. The
responsiveness, rapidity and ease (single label versus
dual) of the RNase H assay has been improved. The ﬂu-
orescence provided by PhpC is suﬃcient to compete with
gel-based techniques on the basis of sensitivity and the
assay can be adapted to multiwell plate format for HTS.
This was also possible because the HIV-1 RT RNase H
cleavage product, the tetranucleotide, showed remarkably
greater ﬂuorescence than even the free nucleoside. Also
uncovered in this study, was the surprising and unprece-
dented observation that oligomer PhpC-2 showed an
increase in ﬂuorescence intensity upon duplex formation.
Together, these observations indicate that PhpC is
signiﬁcantly diﬀerent from MepC and warrants further
investigation on the aﬀects of sequence length and com-
position on changes in ﬂuorescence. Overall, this report
lays the framework for a sensitive and rapid assay for
RNase H activity and inhibitors thereof. We feel that
PhpC will contribute to the growing repertoire of useful
ﬂuorescent nucleobase analogs such as tC , which also
shows red-shifted ﬂuorescence and a high quantum yield
(=0.3) but whose ﬂuorescence is insensitive to duplex
formation (38).
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